# Dexlansoprazole

NDC: 0378-2086
Generic name: dexlansoprazole
Labeler / Manufacturer: Mylan Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, DELAYED RELEASE PELLETS
Routes: ORAL
Marketing started: 20240122

FDA application: ANDA205205

## Active ingredients

- DEXLANSOPRAZOLE SESQUIHYDRATE: 60 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0378-2086"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0378-2086
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3f9699b5-7614-41cb-bd1d-ff02930e98f3